5-HT3 antagonist (Sparsha Pharma)

N/A

Report date: 2025/01/26 19:09:08
NME

Base Information

Drug Name5-HT3 antagonist (Sparsha Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSparsha Pharma International Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSparsha Pharma International Pvt Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A